Securian Asset Management Inc. Has $1.18 Million Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Securian Asset Management Inc. trimmed its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 2.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,005 shares of the biotechnology company’s stock after selling 100 shares during the period. Securian Asset Management Inc.’s holdings in Axon Enterprise were worth $1,178,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in AXON. Vanguard Group Inc. boosted its stake in Axon Enterprise by 2.7% during the first quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock valued at $2,547,878,000 after buying an additional 212,401 shares during the period. Sands Capital Management LLC increased its stake in shares of Axon Enterprise by 0.6% in the 4th quarter. Sands Capital Management LLC now owns 2,628,652 shares of the biotechnology company’s stock worth $679,060,000 after purchasing an additional 16,347 shares in the last quarter. Norges Bank purchased a new stake in shares of Axon Enterprise in the 4th quarter worth $195,406,000. Westfield Capital Management Co. LP boosted its holdings in shares of Axon Enterprise by 5.1% during the 4th quarter. Westfield Capital Management Co. LP now owns 731,721 shares of the biotechnology company’s stock valued at $189,025,000 after purchasing an additional 35,528 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Axon Enterprise by 2.8% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 580,757 shares of the biotechnology company’s stock valued at $150,027,000 after purchasing an additional 15,840 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Trading Up 0.9 %

Axon Enterprise stock traded up $3.35 during trading hours on Monday, hitting $368.35. The stock had a trading volume of 339,179 shares, compared to its average volume of 525,852. The company has a quick ratio of 2.55, a current ratio of 2.91 and a debt-to-equity ratio of 0.37. The stock has a market cap of $27.80 billion, a price-to-earnings ratio of 106.73, a P/E/G ratio of 6.65 and a beta of 0.95. Axon Enterprise, Inc. has a one year low of $189.12 and a one year high of $375.95. The business’s 50 day simple moving average is $300.84 and its 200-day simple moving average is $296.85.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, topping the consensus estimate of $1.02 by $0.18. Axon Enterprise had a return on equity of 9.73% and a net margin of 16.06%. The business had revenue of $504.00 million during the quarter, compared to analysts’ expectations of $478.35 million. During the same quarter last year, the firm posted $0.80 earnings per share. The firm’s revenue was up 34.5% on a year-over-year basis. On average, equities analysts predict that Axon Enterprise, Inc. will post 2.35 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on AXON shares. Jefferies Financial Group started coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They set a “buy” rating and a $385.00 price objective on the stock. Northland Securities upped their target price on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a research note on Thursday. Craig Hallum increased their target price on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a report on Wednesday, August 7th. William Blair reiterated an “outperform” rating on shares of Axon Enterprise in a research report on Wednesday, April 24th. Finally, Robert W. Baird raised their price objective on shares of Axon Enterprise from $355.00 to $360.00 and gave the company an “outperform” rating in a research report on Wednesday, August 7th. Two analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $358.08.

Insider Buying and Selling

In other Axon Enterprise news, Director Julie A. Cullivan sold 993 shares of Axon Enterprise stock in a transaction on Friday, May 31st. The shares were sold at an average price of $281.72, for a total transaction of $279,747.96. Following the transaction, the director now directly owns 4,553 shares of the company’s stock, valued at approximately $1,282,671.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Axon Enterprise news, Director Julie A. Cullivan sold 478 shares of Axon Enterprise stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $286.04, for a total transaction of $136,727.12. Following the transaction, the director now directly owns 5,546 shares of the company’s stock, valued at approximately $1,586,377.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Julie A. Cullivan sold 993 shares of the business’s stock in a transaction dated Friday, May 31st. The stock was sold at an average price of $281.72, for a total transaction of $279,747.96. Following the completion of the transaction, the director now directly owns 4,553 shares in the company, valued at $1,282,671.16. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.